| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 13/05/2024 | 12:05 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NASDAQ:VALN | Valneva SE |
| 14/02/2024 | 14:59 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:VALN | Valneva SE |
| 10/11/2023 | 00:35 | Dow Jones News | FDA Approves Valneva's Chikungunya Virus Vaccine | NASDAQ:VALN | Valneva SE |
| 21/09/2023 | 13:40 | IH Market News | Thursday’s Wall Street Highlights: FedEx, Broadcom, Nio, Klaviyo, Starbucks, and more | NASDAQ:VALN | Valneva SE |
| 14/08/2023 | 09:55 | Dow Jones News | Valneva Shares Slump After FDA Postpones Chikungunya Vaccine Review Date | NASDAQ:VALN | Valneva SE |
| 14/08/2023 | 08:18 | Dow Jones News | Valneva Says FDA Has Delayed Chikungunya Vaccine Review Date | NASDAQ:VALN | Valneva SE |
| 30/06/2023 | 15:00 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:VALN | Valneva SE |
| 22/06/2023 | 23:00 | Edgar (US Regulatory) | Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) | NASDAQ:VALN | Valneva SE |
| 05/05/2023 | 00:28 | Dow Jones News | ADRs End Mostly Lower; Embraer, Valneva Trade Actively | NASDAQ:VALN | Valneva SE |
| 17/02/2023 | 09:13 | Dow Jones News | Valneva, Pfizer to Discontinue Some Trials for Lyme Disease Vaccine | NASDAQ:VALN | Valneva SE |
| 05/12/2022 | 10:19 | Dow Jones News | Valneva Shares Gain After Positive Vaccine Trial Results | NASDAQ:VALN | Valneva SE |
| 01/12/2022 | 15:35 | TipRanks | H.C. Wainwright Sticks to Their Buy Rating for Valneva (VALN) | NASDAQ:VALN | Valneva SE |
| 16/11/2022 | 16:00 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:VALN | Valneva SE |
| 30/09/2022 | 22:20 | TipRanks | Analysts Offer Insights on Healthcare Companies: Sintx Technologies (SINT), Motus Gi Holdings (MOTS) and Valneva (VALN) | NASDAQ:VALN | Valneva SE |
| 26/09/2022 | 15:05 | TipRanks | H.C. Wainwright Sticks to Its Buy Rating for Valneva (VALN) | NASDAQ:VALN | Valneva SE |
| 19/09/2022 | 11:57 | TipRanks | Valneva (NASDAQ:VALN) Slides on Ending COVID-19 Vaccine Collaboration | NASDAQ:VALN | Valneva SE |
| 08/09/2022 | 15:25 | TipRanks | H.C. Wainwright Keeps Their Buy Rating on Valneva (VALN) | NASDAQ:VALN | Valneva SE |
| 08/09/2022 | 07:00 | Business Wire | Valneva and VBI Vaccines Announce European Partnership for Marketing and Distribution of PreHevbri® | NASDAQ:VALN | Valneva SE |
| 24/08/2022 | 14:15 | TipRanks | H.C. Wainwright Reaffirms Their Buy Rating on Valneva (VALN) | NASDAQ:VALN | Valneva SE |
| 22/08/2022 | 12:04 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:VALN | Valneva SE |
| 18/08/2022 | 15:20 | TipRanks | Analysts’ Top Healthcare Picks: Curis (CRIS), Valneva (VALN) | NASDAQ:VALN | Valneva SE |
| 12/08/2022 | 22:43 | Edgar (US Regulatory) | Securities Registration (foreign Private Issuer) (f-3) | NASDAQ:VALN | Valneva SE |
| 12/08/2022 | 12:03 | Edgar (US Regulatory) | Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a) | NASDAQ:VALN | Valneva SE |
| 08/08/2022 | 23:36 | Dow Jones News | Pfizer, Valneva Initiate Phase 3 Study of Lyme Disease Vaccine VLA15 | NASDAQ:VALN | Valneva SE |
| 08/08/2022 | 22:45 | Business Wire | Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15 | NASDAQ:VALN | Valneva SE |
| 03/08/2022 | 12:15 | TipRanks | Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY) and Valneva (VALN) | NASDAQ:VALN | Valneva SE |
| 20/07/2022 | 23:55 | Dow Jones News | ADRs End Lower; Valneva, Tokio Marine Trade Actively | NASDAQ:VALN | Valneva SE |
| 27/06/2022 | 14:28 | TipRanks | Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM) and Valneva (VALN) | NASDAQ:VALN | Valneva SE |
| 20/06/2022 | 13:28 | TipRanks | Here’s What Pfizer & Valneva Announced on Monday | NASDAQ:VALN | Valneva SE |
| 20/06/2022 | 07:00 | Business Wire | Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15 | NASDAQ:VALN | Valneva SE |